網(wǎng)頁標(biāo)題: | |
用 戶 名: | ||
---|---|---|
聯(lián) 系 人: | 性 別: | |
密 碼: | ||
重復(fù)密碼: | ||
電子郵箱: | ||
郵箱驗(yàn)證碼: | ||
固定電話: | ||
傳 真: | ||
手 機(jī): | ||
單位名稱: | ||
通信地址: | ||
首選欄目: | ||
我已經(jīng)認(rèn)真閱讀并同意《健康網(wǎng)服務(wù)條款》 | ||
確定注冊(cè) |
· In 2024, China exported more t... | 2025-03-05 10:50:01 |
· Imipenem parent nucleus refere... | 2025-02-21 16:50:45 |
· Erythromycin Ethylsuccinate re... | 2024-11-22 16:50:41 |
· C型尼曼匹克氏癥新藥!FDA批準(zhǔn)levacetylleuci... | 2024-10-09 15:26:26 |
· Erythromycin Ethylsuccinate re... | 2024-09-20 13:48:05 |
· The latest price of inositol i... | 2024-08-09 17:12:57 |
· 衛(wèi)材授予佐藤制藥氟沙康挫在亞洲和大洋洲獨(dú)家開發(fā)和商業(yè)化權(quán)益 | 2024-07-22 10:49:34 |
· 強(qiáng)生/傳奇生物CAR-T療法新適應(yīng)癥獲FDA批準(zhǔn) | 2024-04-07 14:20:54 |
· 藥品合規(guī)營銷(UCPMP)取得一定進(jìn)展 | 2024-03-21 10:25:37 |
· Erythromycin Ethylsuccinate re... | 2024-03-15 17:12:53 |
· DoP為制藥和醫(yī)療器械公司發(fā)布新的UCPMP | 2024-03-13 14:04:43 |
· 全球首款腫瘤浸潤淋巴細(xì)胞療法獲FDA批準(zhǔn)上市 | 2024-02-23 16:31:02 |
· The latest price of inositol i... | 2024-02-06 16:59:07 |
· Erythromycin Ethylsuccinate re... | 2023-12-20 17:08:43 |
· On December 18th, Weizhuo (Jia... | 2023-12-20 14:40:57 |
· Erythromycin Ethylsuccinate re... | 2023-11-17 15:34:38 |
· 全身性重癥肌無力新藥Zilbrysq(zilucoplan)... | 2023-10-19 17:37:12 |
· 晚發(fā)型龐貝氏癥療法Pombiliti+Opfolda獲FDA... | 2023-10-19 17:15:39 |
· Erythromycin Ethylsuccinate re... | 2023-09-15 13:47:18 |
· Erythromycin Ethylsuccinate re... | 2023-08-18 14:55:12 |
· High-end API production projec... | 2023-07-07 16:50:48 |
· The legendary Bio-Citagiorence... | 2023-06-08 10:51:27 |
· Changes of global supply chain... | 2023-05-16 11:08:15 |
· L-Isoleucine reference price | 2023-03-10 15:01:06 |
· Erythromycin Ethylsuccinate re... | 2023-03-03 13:43:44 |
· Erythromycin Ethylsuccinate re... | 2023-02-22 15:24:02 |
· Jiangsu Yuanda Yue Xian Pharma... | 2023-02-10 15:49:47 |
· 渤健阿爾茨海默病抗體療法aducanumab在中國申報(bào)臨床 | 2023-02-09 16:23:27 |
· Yunnan Zewei Pharmaceutical Co... | 2023-01-12 14:36:46 |
· Erythromycin Ethylsuccinate re... | 2022-12-16 18:33:14 |
· 2022年全球新上市十大重磅創(chuàng)新藥品 | 2022-12-15 10:29:03 |
· Erythromycin Ethylsuccinate re... | 2022-11-09 11:19:06 |
· Erythromycin Ethylsuccinate re... | 2022-10-14 15:21:30 |
· Atorvastatin parent nucleus (L... | 2022-10-14 14:33:45 |
· Vitamin C glucoside reference ... | 2022-09-20 15:53:32 |
· 全球首個(gè)TYK2抑制劑deucravacitinib亞洲人群... | 2022-09-16 16:01:01 |
· Paracetamol reference prices o... | 2022-08-10 11:23:55 |
· Erythromycin Ethylsuccinate re... | 2022-07-15 16:00:20 |
· Erythromycin Ethylsuccinate re... | 2022-06-17 17:30:18 |
· 諾華CAR-T療法Kymriah(tisagenlecleu... | 2022-05-31 15:40:44 |
· Atorvastatin parent nucleus (M... | 2022-05-19 15:42:54 |
· 百時(shí)美施貴寶口服TYK2變構(gòu)抑制劑deucravacitin... | 2022-05-16 11:43:24 |
· Erythromycin Ethylsuccinate re... | 2022-05-14 20:00:43 |
· Paracetamol reference prices o... | 2022-04-28 17:20:17 |
· Analysis of The Domestic Tetra... | 2022-04-27 17:35:06 |
· The First TCR-T Product For Th... | 2022-04-22 12:10:45 |
· Erythromycin Ethylsuccinate re... | 2022-04-13 16:43:25 |
· In 2021, The Export Volume of ... | 2022-03-29 17:27:44 |
· 百健與衛(wèi)材修訂阿爾茨海默病藥物Aduhelm合作協(xié)議 | 2022-03-15 15:25:29 |
· The New Crown Antigen Self-Tes... | 2022-03-15 14:47:43 |
|